First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
| Image |  |
|---|---|
| Description | journal article from 'The Lancet' published in 2021 |
| Author/s |
author: Lucjan S Wyrwicz Tomasz Skoczylas |
| Publication date | July 2021 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://linkinghub.elsevier.com/retrieve/pii/S0140673621007972 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |